Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 2953939)

Published in Hum Reprod Update on May 28, 2010

Authors

Lee Hooper1, Giri Madhavan, Jeffrey A Tice, Sam J Leinster, Aedín Cassidy

Author Affiliations

1: SRD Senior Lecturer in Research Synthesis and Nutrition, School of Medicine, University of East Anglia, Health Policy and Practice, Norwich NR4 7TJ, Norfolk, UK. l.hooper@uea.ac.uk

Articles citing this

Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal (2012) 1.96

The volume of nipple aspirate fluid is not affected by 6 months of treatment with soy foods in premenopausal women. J Nutr (2011) 1.14

Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk. Am J Clin Nutr (2011) 0.97

Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective. Curr Med Chem (2014) 0.96

Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: a meta-analysis of epidemiological studies. PLoS One (2014) 0.96

Redefining the impact of nutrition on breast cancer incidence: is epigenetics involved? Nutr Res Rev (2012) 0.93

Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D. Osteoporos Int (2012) 0.93

Nutrition and healthy ageing: calorie restriction or polyphenol-rich "MediterrAsian" diet? Oxid Med Cell Longev (2013) 0.93

Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study. Eur J Nutr (2013) 0.89

Does equol production determine soy endocrine effects? Eur J Nutr (2012) 0.87

Genetic variation in peroxisome proliferator-activated receptor gamma, soy, and mammographic density in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev (2012) 0.86

Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature. Nutrients (2016) 0.85

Mammographic breast density and serum phytoestrogen levels. Nutr Cancer (2012) 0.79

Diet across the Lifespan and the Association with Breast Density in Adulthood. Int J Breast Cancer (2013) 0.78

Soy food supplementation, dietary fat reduction and peripheral blood gene expression in postmenopausal women--a randomized, controlled trial. Mol Nutr Food Res (2011) 0.76

Equol-producing status, isoflavone intake, and breast density in a sample of U.S. Chinese women. Cancer Epidemiol Biomarkers Prev (2013) 0.76

Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial. Am J Clin Nutr (2015) 0.76

Does consuming isoflavones reduce or increase breast cancer risk? Genome Med (2010) 0.75

Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials. Oncotarget (2016) 0.75

Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density. Cancer Prev Res (Phila) (2015) 0.75

Cytology in nipple aspirate fluid during a randomized soy food intervention among premenopausal women. Nutr Cancer (2013) 0.75

Articles cited by this

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst (1989) 19.87

Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ (2003) 18.72

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (2008) 11.08

Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 10.35

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst (2002) 9.65

Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol (2007) 3.84

Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst (2003) 3.83

Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA (2004) 3.77

Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer (1976) 3.37

Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr (1994) 3.25

Soy food intake and breast cancer survival. JAMA (2009) 3.16

Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res (2008) 3.05

Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. J Natl Cancer Inst (1998) 2.86

Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst (2006) 2.79

Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res (2007) 2.71

Mammographic density. Measurement of mammographic density. Breast Cancer Res (2008) 2.64

Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med (2007) 2.54

Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. J Natl Cancer Inst (1997) 2.46

Dietary isoflavones: biological effects and relevance to human health. J Nutr (1999) 2.45

Nongenomic steroid action: controversies, questions, and answers. Physiol Rev (2003) 2.41

Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35

Epidemiology of soy exposures and breast cancer risk. Br J Cancer (2008) 2.22

A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr (2004) 2.04

Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis (2002) 2.01

Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update (2009) 1.99

Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst (2006) 1.85

Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr (2002) 1.82

The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. Environ Health Perspect (2003) 1.80

Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res (1998) 1.79

Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep (2001) 1.78

Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med (2007) 1.76

Side effects of phytoestrogens: a meta-analysis of randomized trials. Am J Med (2009) 1.51

Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis (1996) 1.44

Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr (2000) 1.41

Is equol the key to the efficacy of soy foods? Am J Clin Nutr (2009) 1.36

Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev (2009) 1.35

Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res (2009) 1.35

Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.24

Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab (1999) 1.24

Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res (2001) 1.24

Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J Nutr (2001) 1.15

Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J Clin Endocrinol Metab (2008) 1.10

Mammographic density changes during the menstrual cycle. Cancer Epidemiol Biomarkers Prev (2001) 1.09

Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis (2004) 1.08

Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat (2006) 1.08

Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res (2004) 1.07

Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev (2003) 1.06

Mammographic breast density, dense area, and breast area differences by phase in the menstrual cycle. Cancer Epidemiol Biomarkers Prev (2006) 1.05

Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis (2003) 1.04

Longitudinal association of anthropometry with mammographic breast density in the Study of Women's Health Across the Nation. Int J Cancer (2009) 1.00

Perspectives on the soy-breast cancer relation. Am J Clin Nutr (2009) 1.00

Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women. Cancer Causes Control (2009) 0.98

Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study. Menopause (2009) 0.98

Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am J Clin Nutr (2005) 0.97

Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc Soc Exp Biol Med (1998) 0.96

A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol Biomarkers Prev (2002) 0.95

Differences in measured mammographic density in the menstrual cycle. Cancer Epidemiol Biomarkers Prev (2009) 0.93

Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer. Menopause Int (2008) 0.93

Exogenous and endogenous hormones, mammographic density and breast cancer risk: can mammographic density be considered an intermediate marker of risk? Recent Results Cancer Res (2009) 0.93

Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 0.91

Various doses of soy isoflavones do not modify mammographic density in postmenopausal women. J Nutr (2009) 0.91

Dietary sources of lignans and isoflavones modulate responses to estradiol in estrogen reporter mice. Mol Nutr Food Res (2009) 0.88

Estrogen/isoflavone interactions in cynomolgus macaques (Macaca fascicularis). Am J Primatol (2009) 0.87

Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice. Int J Cancer (2006) 0.87

Soy isoflavones, body composition, and physical performance. Maturitas (2005) 0.86

Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women. Osteoporos Int (2009) 0.86

Mammographic density using two computer-based methods in an isoflavone trial. Maturitas (2008) 0.85

Physical activity and mammographic breast density in a Mediterranean population: the EPIC Florence longitudinal study. Int J Cancer (2009) 0.84

Report on the 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment. J Nutr (2009) 0.84

Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts. Int J Cancer (2006) 0.81

A randomized, placebo-controlled trial on the effects of soy protein containing isoflavones on quality of life in postmenopausal women. Menopause (2005) 0.79

Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model. Bone (2006) 0.78

The safety and benefits of soybean isoflavones. A natural alternative to conventional hormone therapy? Menopause (2007) 0.77

Design and baseline characteristics of a trial on health effects of soy protein with isoflavones in postmenopausal women. Maturitas (2004) 0.76

Flaxseed and soy protein isolate, alone and in combination, differ in their effect on bone mass, biomechanical strength, and uterus in ovariectomized nude mice with MCF-7 human breast tumor xenografts. J Toxicol Environ Health A (2007) 0.76

Articles by these authors

Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17

Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2008) 3.84

Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med (2004) 3.64

Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Ann Intern Med (2006) 2.73

Targeting sedentary time or moderate- and vigorous-intensity activity: independent relations with adiposity in a population-based sample of 10-y-old British children. Am J Clin Nutr (2009) 2.49

Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46

Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35

Are breast density and bone mineral density independent risk factors for breast cancer? J Natl Cancer Inst (2005) 2.21

The Dundee Ready Education Environment Measure (DREEM): a review of its adoption and use. Med Teach (2012) 1.85

Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr (2012) 1.84

Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr (2012) 1.78

Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin. J Gen Intern Med (2009) 1.77

Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis. Arch Intern Med (2007) 1.77

Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial. Diabetes Care (2012) 1.58

Medical students' perceptions of their educational environment: expected versus actual perceptions. Med Educ (2007) 1.54

Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis. Am Heart J (2012) 1.46

Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-tracer study. Am J Clin Nutr (2013) 1.39

Local food outlets, weight status, and dietary intake: associations in children aged 9-10 years. Am J Prev Med (2011) 1.26

Statistics teaching in medical school: opinions of practising doctors. BMC Med Educ (2010) 1.25

Relative impact of flavonoid composition, dose and structure on vascular function: a systematic review of randomised controlled trials of flavonoid-rich food products. Mol Nutr Food Res (2012) 1.20

Who is responsible for evaluating the safety and effectiveness of medical devices? The role of independent technology assessment. J Gen Intern Med (2008) 1.20

Do doctors need statistics? Doctors' use of and attitudes to probability and statistics. Stat Med (2009) 1.18

Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am J Clin Nutr (2012) 1.14

Environmental correlates of adiposity in 9-10 year old children: considering home and school neighbourhoods and routes to school. Soc Sci Med (2011) 1.13

Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT. Carcinogenesis (2013) 1.13

An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia. Medicine (Baltimore) (2005) 1.08

What does my patient's coronary artery calcium score mean? Combining information from the coronary artery calcium score with information from conventional risk factors to estimate coronary heart disease risk. BMC Med (2004) 1.06

Impact of neighbourhood food environment on food consumption in children aged 9-10 years in the UK SPEEDY (Sport, Physical Activity and Eating behaviour: Environmental Determinants in Young people) study. Public Health Nutr (2009) 1.02

Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 1.02

Comparing staff and student perceptions of the student experience at a new medical school. Med Teach (2009) 1.00

The impact of rainfall and school break time policies on physical activity in 9-10 year old British children: a repeated measures study. Int J Behav Nutr Phys Act (2011) 0.96

Diet quality is independently associated with weight status in children aged 9-10 years. J Nutr (2011) 0.96

Medical students' perceptions of peer feedback on an anatomy student-selected study module. Med Teach (2008) 0.95

Cardiovascular disease risk biomarkers and liver and kidney function are not altered in postmenopausal women after ingesting an elderberry extract rich in anthocyanins for 12 weeks. J Nutr (2009) 0.95

Intakes of anthocyanins and flavones are associated with biomarkers of insulin resistance and inflammation in women. J Nutr (2013) 0.95

Identifying professional characteristics of the ideal medical doctor: the laddering technique. Med Teach (2010) 0.93

Associations between eating frequency, adiposity, diet, and activity in 9-10 year old healthy-weight and centrally obese children. Obesity (Silver Spring) (2012) 0.92

Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort. Endocr Relat Cancer (2013) 0.92

Cross-sectional evaluation of a longitudinal consultation skills course at a new UK medical school. BMC Med Educ (2011) 0.90

School level correlates with adiposity in 9-10 year old children. Health Place (2011) 0.90

Phenolic metabolites of anthocyanins following a dietary intervention study in post-menopausal women. Mol Nutr Food Res (2013) 0.88

Habitual flavonoid intakes are positively associated with bone mineral density in women. J Bone Miner Res (2012) 0.86

Perceived versus objective breast cancer risk in diverse women. J Womens Health (Larchmt) (2013) 0.86

Diet and bone mineral density study in postmenopausal women from the TwinsUK registry shows a negative association with a traditional English dietary pattern and a positive association with wine. Am J Clin Nutr (2011) 0.85

Epidemiologic studies of isoflavones & mammographic density. Nutrients (2010) 0.84

Phenolic metabolites of anthocyanins modulate mechanisms of endothelial function. J Agric Food Chem (2015) 0.83

Positive effect of a targeted intervention to improve access and availability of fruit and vegetables in an area of deprivation. Health Place (2012) 0.82

Does a summative portfolio foster the development of capabilities such as reflective practice and understanding ethics? An evaluation from two medical schools. Med Teach (2012) 0.81

Alternatives to estrogen for treatment of hot flashes: are they effective and safe? JAMA (2006) 0.81

Use of coronary calcification scores to predict coronary heart disease. JAMA (2004) 0.81

Effect of isoflavones on lipids and bone turnover markers in menopausal women. Maturitas (2004) 0.80

Food and drink consumption at school lunchtime: the impact of lunch type and contribution to overall intake in British 9-10-year-old children. Public Health Nutr (2011) 0.80

Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial. Am J Clin Nutr (2013) 0.79

"On the other hand ...": the evidence does not support the use of hand-carried ultrasound by hospitalists. J Hosp Med (2010) 0.78

Modeling cardiovascular disease prevention. JAMA (2010) 0.77

Effect of phytochemicals on phase II enzyme expression in infant human primary skin fibroblast cells. Br J Nutr (2012) 0.76

Vitamin D as a mediator of racial differences in blood pressure. J Gen Intern Med (2011) 0.75

Evidence at the point of practice change: lung cancer screening. Arch Intern Med (2012) 0.75

Point-counterpoint: soy intake for breast cancer patients. Integr Cancer Ther (2002) 0.75